It is broadly acknowledged that the onset of dementia in Alzheimer's disease (AD) may be
modifiable by the management of risk factors. While several recent guidelines and …

Objective To describe the comparative efficacy of drug and non-drug interventions for
reducing symptoms of depression in people with dementia who experience depression as a …

Background The use of antidepressants in dementia accompanied by depressive symptoms
is widespread, but their clinical efficacy is uncertain. This review updates an earlier version …

Objective: Depression is associated with an increased risk of Alzheimer's disease. Research
has shown that the selective serotonin reuptake inhibitor (SSRI) citalopram decreases …

Depression and Alzheimer's disease (AD) are substantial public health concerns. In the past
decades, a link between the 2 disease entities has received extensive acknowledgment, yet …

Alzheimer's disease (AD) is a complex neurodegenerative disorder that affects multiple
brain regions and is difficult to treat. In this study we used 22 AD large-scale gene …

Aside from its roles in as a classical neurotransmitter involved in regulation of behavior,
noradrenaline (NA) has other functions in the CNS. This includes restricting the …

Neuropsychiatric symptoms of Alzheimer's disease (NPS-AD) are highly prevalent and lead
to poor medical and functional outcomes. In spite of the burdensome nature of NPS-AD, we …

Background The purpose of this study was to investigate the associations between courses
of depression, the application of depression treatment, and the risk of incident dementia …

Background: Alzheimer's disease (AD) and other forms of dementia are among the most
common causes of disability in the elderly. Dementia is often accompanied by depression …